GGrantIndex
← Leaderboards

Maria Luisa Alcaide

University Of Miami School Of Medicine

$22,537,176
Attributed
$53,705,791
Total exposure
10
Grants
8
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $18.5M · FY201225
$20M$15M$10M$5M$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$61,493,919 · 11

By mechanism

R01$26,995,515 · 4
U01$18,080,014 · 1
U19$14,036,054 · 2
P30$1,850,476 · 3
K23$531,860 · 1

Most similar at University Of Miami School Of Medicine

Same institution · by research overlap

Others in their field

Top investigators on “Affect

Research focus

AffectWomanCohortResearch PersonnelCommunitiesInflammationEpidemicHiv InfectionsBiologicalBehavioralLaboratoriesEnrollmentIncidenceSpecimenUnited StatesLeadershipData CollectionSiteWomen&AposAreaSample CollectionVisitRecruitInnovation

Grant awards (51)

Study of Treatment And Reproductive outcomes$7,788,128
U19 · FY2025 · HD · contact PI
SCIENTIFIC ADMINISTRATIVE CORE (SAC)$6,247,926
U19 · FY2025 · HD · contact PI
MACS/WIHS -CCS$2,590,415
U01 · FY2025 · HL · contact PI
A Phylodynamic Artificial Intelligence framework to predict evolution of SARS-CoV-2 variants of concern in Immunocompromised persons with HIV (PhAI-CoV)$725,727
R01 · FY2025 · AI
The CROWN study: Comprehensive Research on Oral and mental health among WomeN$635,546
R01 · FY2025 · DE
Clinical Sciences Core$250,000
P30 · FY2025 · AI · contact PI
SOURI (SMILE)$213,135
R01 · FY2025 · DE
Women HIV Cohort Study: HIV infection and treatment among women of reproductive age$3,672,647
R01 · FY2024 · HD · contact PI
MACS/WIHS -CCS$2,554,017
U01 · FY2024 · HL · contact PI
A Phylodynamic Artificial Intelligence framework to predict evolution of SARS-CoV-2 variants of concern in Immunocompromised persons with HIV (PhAI-CoV)$738,604
R01 · FY2024 · AI
The CROWN study: Comprehensive Research on Oral and mental health among WomeN$614,764
R01 · FY2024 · DE
Clinical Sciences Core$126,299
P30 · FY2024 · AI · contact PI
MACS/WIHS -CCS$2,569,967
U01 · FY2023 · HL · contact PI
A Phylodynamic Artificial Intelligence framework to predict evolution of SARS-CoV-2 variants of concern in Immunocompromised persons with HIV (PhAI-CoV)$744,241
R01 · FY2023 · AI
Mechanisms underlying recurrent bacterial vaginosis and HIV risk A Multidisciplinary approach$635,997
R01 · FY2023 · AI · contact PI
The CROWN study: Comprehensive Research on Oral and mental health among WomeN$635,251
R01 · FY2023 · DE
Clinical Sciences Core$233,470
P30 · FY2023 · AI · contact PI
Women HIV Cohort Study: HIV infection and treatment among women of reproductive age$3,767,324
R01 · FY2022 · HD · contact PI
MACS/WIHS -CCS$2,629,147
U01 · FY2022 · HL
A Phylodynamic Artificial Intelligence framework to predict evolution of SARS-CoV-2 variants of concern in Immunocompromised persons with HIV (PhAI-CoV)$776,744
R01 · FY2022 · AI
Mechanisms underlying recurrent bacterial vaginosis and HIV risk A Multidisciplinary approach$728,666
R01 · FY2022 · AI · contact PI
Clinical Sciences Core$227,199
P30 · FY2022 · AI · contact PI
MACS/WIHS -CCS-Supplement$14,148
U01 · FY2022 · HL
Women HIV Cohort Study: HIV infection and treatment among women of reproductive age$3,845,346
R01 · FY2021 · HD · contact PI
MACS/WIHS -CCS$2,599,372
U01 · FY2021 · HL
Clinical Sciences Core (Core C)$222,734
P30 · FY2021 · AI · contact PI
Innovation Fund Application to the Multicenter AIDS Cohort Study (MACS)/Womens Interagency HIV Study (WIHS) Combined Cohort Study (MWCCS): COVID-19 Vaccine Acceptance and Hesitancy (CVHB)$33,764
U01 · FY2021 · HL
Women HIV Cohort Study: HIV infection and treatment among women of reproductive age$3,035,518
R01 · FY2020 · HD · contact PI
MACS/WIHS -CCS$2,485,217
U01 · FY2020 · HL
Mechanisms underlying recurrent bacterial vaginosis and HIV risk A Multidisciplinary approach$731,817
R01 · FY2020 · AI · contact PI
Women HIV Cohort Study: HIV infection and treatment among women of reproductive age$518,860
R01 · FY2020 · HD · contact PI
Women HIV Cohort Study: HIV infection and treatment among women of reproductive age$500,000
R01 · FY2020 · HD · contact PI
Clinical Sciences Core (Core C)$232,740
P30 · FY2020 · AI · contact PI
Women HIV Cohort Study: HIV infection and treatment among women of reproductive age$122,231
R01 · FY2020 · HD · contact PI
MACS/WIHS -CCS$50,218
U01 · FY2020 · HL
MACS/WIHS -CCS$25,171
U01 · FY2020 · HL
MACS/WIHS -CCS$20,095
U01 · FY2020 · HL
MACS/WIHS -CCS$17,732
U01 · FY2020 · HL
Women HIV Cohort Study: HIV infection and treatment among women of reproductive age$2,900,790
R01 · FY2019 · HD · contact PI
MACS/WIHS -CCS$2,000,000
U01 · FY2019 · HL
Mechanisms underlying recurrent bacterial vaginosis and HIV risk A Multidisciplinary approach$735,069
R01 · FY2019 · AI · contact PI
MACS/WIHS -CCS$469,240
U01 · FY2019 · HL
Clinical Sciences Core (Core C)$302,808
P30 · FY2019 · AI · contact PI
MACS/WIHS -CCS$21,511
U01 · FY2019 · HL
Mechanisms underlying recurrent bacterial vaginosis and HIV risk A Multidisciplinary approach$717,238
R01 · FY2018 · AI · contact PI
Clinical Sciences Core (Core C)$255,226
P30 · FY2018 · AI · contact PI
Vaginal practices in HIV positive women in Zambia a bio-behavioral intervention$104,206
K23 · FY2016 · HD · contact PI
Vaginal practices in HIV positive women in Zambia a bio-behavioral intervention$106,237
K23 · FY2015 · HD · contact PI
Vaginal practices in HIV positive women in Zambia a bio-behavioral intervention$106,474
K23 · FY2014 · HD · contact PI
Vaginal practices in HIV positive women in Zambia a bio-behavioral intervention$106,904
K23 · FY2013 · HD · contact PI
Vaginal practices in HIV positive women in Zambia a bio-behavioral intervention$108,039
K23 · FY2012 · HD · contact PI